SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Technology Stocks & Market Talk With Don Wolanchuk
SOXL 48.79-1.7%Dec 11 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Winfastorlose who wrote (173774)5/21/2022 2:39:00 AM
From: TigerPaw  Read Replies (2) of 207309
 
What you don't understand ...
well , one of the things you don't understand is that the mRNA vaccines use a very small targeted bit of the covid virus to stimulate antibodies, so the antibodies are limited to this small target.

A natural infection stimulates antibodies to all sorts of viral fragments, some of which are hopefully unique to the dangerous form of covid, but others are neutral fragments, or slight variations of fragments that are also being a template. The antibody load is higher but much of it does not necessarily code for the specific covid virus or duplicates the action of another antibody. Not only this, but actual virus contain stretches of information that are pretty generic to all living cells, and if your body develops an antibody to a generic fragment it can cause an allergy to that bit of DNA whether it comes from a covid or some benign food that you eat.

The mRna vaccines are designed to fill your body with the minimum amount of antibodies to prevent, or retard infection, and that's a good thing.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext